Filing Details

Accession Number:
0001384101-22-000114
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-09 17:16:52
Reporting Period:
2022-08-05
Accepted Time:
2022-08-09 17:16:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1384101 Veracyte Inc. VCYT Services-Medical Laboratories (8071) 205455398
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1588970 H Bonnie Anderson 6000 Shoreline Court
Suite 300
South San Francisco CA 94080
Executive Chairwoman Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-08-05 76,917 $27.71 157,426 No 4 S Indirect The Bonnie H. Anderson Living Trust
Common Stock Disposition 2022-08-08 39,231 $27.24 118,195 No 4 S Indirect The Bonnie H. Anderson Living Trust
Common Stock Disposition 2022-08-08 5,769 $27.82 112,426 No 4 S Indirect The Bonnie H. Anderson Living Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect The Bonnie H. Anderson Living Trust
No 4 S Indirect The Bonnie H. Anderson Living Trust
No 4 S Indirect The Bonnie H. Anderson Living Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 67,045 Direct
Footnotes
  1. Represents weighted average sales price. Sale prices for the transactions range from $27.09 to $28.06. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  2. Represents weighted average sales price. Sale prices for the transactions range from $26.710 to $27.705. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  3. Represents weighted average sales price. Sale prices for the transactions range from $27.730 to $27.935. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.